Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors. Shao H, Shi L, Fonseca VA. Diabetes Care 2020;43:1530-1536.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shao H, Shi L, Fonseca VA. Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors. Diabetes Care 2020;43:1530-1536.
PMID: 32345650